Clinnovate Health | Publications
Clinnovate Health partners with medtech and healthcare technology providers to build and commercialise novel integrative diagnostic platforms for various research and clinical applications.
clinnovate health, clinnovatehealth, Medtech and Healthcare Technology Providers, Research, Clinical Applications
page-template-default,page,page-id-16395,ajax_fade,page_not_loaded,,qode-theme-ver-7.9,wpb-js-composer js-comp-ver-4.11.1,vc_responsive


Title: Icosabutate, a novel structurally engineered fatty-acid, exhibits potent anti-inflammatory and anti-fibrotic effects in a dietary mouse model resembling progressive human NASH

David A Fraser et al.


Type: Poster

Event: AASLD 2018, San Francisco (Poster #1300)

Title: Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice

Morrison, M. C. et al (2018), Hepatology Communications. doi: 10.1002/hep4.1270


Type: Paper Publication

Title: Phenotypical characteriza7on of intrahepatic cholangiocarcinomas stroma : the more fibrous, the less pejorative

L. Blaise, M. Albuquerque, C. Neuzillet, N. Guedj, J. Cros, V. Paradis INSERM UMR1149 Beaujon Hospital, Clichy, France


Type: Poster

Event: AASLD 2016, Boston